Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Acute Otitis Externa

Acute Otitis Externa Clinical Trial

Official title:
A Phase III, Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of DF289 Plus DF277 Otic Solution Compared to DF289 Otic Solution and to DF277 Otic Solution in the Treatment of Acute Otitis Externa (AOE)

Status Completed

Clinical Trial Summary

The purpose of this study is to determine if a combination of an antibiotic plus a corticosteroid is safe and effective in treating AOE

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03196973
Study type	Interventional
Source	Salvat
Contact
Status	Completed
Phase	Phase 3
Start date	July 22, 2017
Completion date	September 14, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02918773` - Pediatric Emergency Department Smartphone Otoscope Study (PED-Oto)	N/A
Not yet recruiting	`NCT04636957` - A Phase III Study of Ciprofloxacin Plus Fluocinolone in Acute Otitis Externa (AOE)	Phase 3
Completed	`NCT01447017` - A Study of DPK-060 to Investigate Clinical Safety and Efficacy in Patients With Acute External Otitis	Phase 2
Completed	`NCT01535599` - Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa	Phase 3
Completed	`NCT02801370` - Phase 3 Study of OTO-201 in Acute Otitis Externa	Phase 3
Completed	`NCT00750633` - A Phase III Study of an Otic Formulation in Acute Otitis Externa	Phase 3
Terminated	`NCT00945802` - FST-201 In The Treatment of Acute Otitis Externa	Phase 3
Recruiting	`NCT01584271` - Study of Ear Comfort Ear Drops to Treat AOE Cases Compared to DexOtic & Otidin(R)	Phase 2
Completed	`NCT02216071` - Comparative Efficacy and Safety of Ciprofloxacin 0.3% and Dexamethasone 0.1% in Acute Otitis Externa	Phase 3
Completed	`NCT00961675` - FST-201 in the Treatment of Acute Otitis Externa	Phase 3
Completed	`NCT01535560` - Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa	Phase 3